Literature DB >> 15655389

Case studies in hypertension. Dihydropyridine/nondihydropyridine calcium channel blocker combination therapy.

Joe Handler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15655389      PMCID： PMC8109713          DOI： 10.1111/j.1524-6175.2005.04091.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  12 in total

Review 1.  Calcium-antagonist drugs.

Authors:  D R Abernethy; J B Schwartz
Journal:  N Engl J Med       Date:  1999-11-04       Impact factor: 91.245

2.  Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

Authors:  L Liu; J G Wang; L Gong; G Liu; J A Staessen
Journal:  J Hypertens       Date:  1998-12       Impact factor: 4.844

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Combination therapy with verapamil and nitrendipine in patients with hypertension.

Authors:  I Nalbantgil; R Onder; B Kiliçcioğlu; C Türkoğlu
Journal:  J Hum Hypertens       Date:  1993-06       Impact factor: 3.012

Review 5.  Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

Authors:  G L Bakris; M Williams; L Dworkin; W J Elliott; M Epstein; R Toto; K Tuttle; J Douglas; W Hsueh; J Sowers
Journal:  Am J Kidney Dis       Date:  2000-09       Impact factor: 8.860

6.  Comparison of nifedipine alone and with diltiazem or verapamil in hypertension.

Authors:  J J Saseen; B L Carter; T E Brown; W J Elliott; H R Black
Journal:  Hypertension       Date:  1996-07       Impact factor: 10.190

7.  A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial.

Authors:  Carl J Pepine; Eileen M Handberg; Rhonda M Cooper-DeHoff; Ronald G Marks; Peter Kowey; Franz H Messerli; Giuseppe Mancia; José L Cangiano; David Garcia-Barreto; Matyas Keltai; Serap Erdine; Heather A Bristol; H Robert Kolb; George L Bakris; Jerome D Cohen; William W Parmley
Journal:  JAMA       Date:  2003-12-03       Impact factor: 56.272

8.  Diltiazem, nifedipine, and their combination in patients with stable angina pectoris: effects on angina, exercise tolerance, and the ambulatory electrocardiographic ST segment.

Authors:  W Frishman; S Charlap; B Kimmel; M Teicher; J Cinnamon; L Allen; J Strom
Journal:  Circulation       Date:  1988-04       Impact factor: 29.690

9.  Combination therapy with diltiazem and nifedipine in patients with effort angina pectoris.

Authors:  N Toyosaki; T Toyo-oka; T Natsume; T Katsuki; T Tateishi; T Yaginuma; S Hosoda
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

10.  Verapamil and nifedipine in combination for the treatment of hypertension.

Authors:  W H Kaesemeyer; A A Carr; P B Bottini; L M Prisant
Journal:  J Clin Pharmacol       Date:  1994-01       Impact factor: 3.126
View more
  2 in total

1.  Eplerenone as a treatment for resistant hypertension in pregnancy.

Authors:  Jessica Gehlert; Adam Morton
Journal:  Obstet Med       Date:  2019-03-24

2.  Managing chronic severe hypertension in pregnancy.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-10       Impact factor: 3.738
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.